Nishit Shashikant Shah, MD
Pediatric Medicine · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Offices
- 2
Offices
2 locations · Bay Area Community Health · 106 clinicians in this group
Looking this up.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shah’s office at (408) 729-9700 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
State licence records
1 licence
- Texas P7349Physician License · since 2013 · expires 2017-11-30Canc Non-RenewalNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Medicaid work
$1,517,549 in 2024
Medicaid paid $1,517,549 for 21,872 billed services this clinician did in 2024, up to 411 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 4,889 | $1,373,759 |
| Short return visit (20+ min) | 5,881 | $37,930 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 232 | $14,326 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 232 | $12,512 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 351 | $10,404 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 217 | $10,337 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 317 | $9,556 |
| Developmental screening | 558 | $8,996 |
| Short return visit | 1,310 | $6,726 |
| Hepatitis B vaccine (HepB), CpG-adjuvanted, adult dosage, 2 dose or 4 dose schedule, for intramuscular use | 129 | $6,720 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 247 | $5,122 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 118 | $4,242 |
| 2024 | 21,872 | 47 | 411 | $1,517,549 |
| 2023 | 11,996 | 37 | 420 | $965,412 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 3,217 | $887,133 |
| Short return visit (20+ min) | 3,208 | $28,725 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 315 | $8,981 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, tetanus toxoid carrier (MenACWY-TT), for intramuscular use | 174 | $6,359 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 88 | $5,710 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 256 | $5,532 |
| Developmental screening | 213 | $4,397 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 211 | $3,391 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 47 | $1,836 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 102 | $1,552 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 361 | $1,549 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; late childhood (age 5 through 11 years) | 125 | $1,388 |
Money from drug and device companies
$593 in 2025
| 2025 | 11 | 27 | None | $593 |
| 2024 | 9 | 17 | None | $357 |
| 2023 | 5 | 6 | None | $113 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | Yeztugo | $139 | 6 payments
|
| Pfizer | Prevnar 20 | $70 | 3 payments
|
| GlaxoSmithKline | Shingrix | $65 | 3 payments
|
| ViiV Healthcare | Apretude | $55 | 3 payments
|
| Seqirus USA | Fluad | $54 | 2 payments
|
| Novo Nordisk | Wegovy | $46 | 2 payments
|
See all 27 published payments
| Gilead Sciences | Meals · 2025-12-18 | None | $18 |
| Seqirus USA | Meals · 2025-11-13 | Fluad | $29 |
| GlaxoSmithKline | Meals · 2025-11-06 | Shingrix | $17 |
| Novo Nordisk | Meals · 2025-10-30 | Wegovy | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-10-23 | Dupixent | $17 |
| Pfizer | Meals · 2025-10-02 | Prevnar 20 | $25 |
| Gilead Sciences | Meals · 2025-10-02 | None | $25 |
| Merck Sharp & Dohme | Meals · 2025-08-28 | Gardasil 9 | $28 |
| GlaxoSmithKline | Meals · 2025-08-14 | Shingrix | $25 |
| Pfizer | Meals · 2025-08-07 | Prevnar 20 | $21 |
| Gilead Sciences | Meals · 2025-07-31 | Yeztugo | $24 |
| Novo Nordisk | Meals · 2025-07-23 | None | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-07-10 | Dupixent | $15 |
| Dynavax Technologies | Meals · 2025-06-05 | Heplisav-B | $24 |
| Hologic Sales and Service | Meals · 2025-05-15 | Aptima | $15 |
| Merck Sharp & Dohme | Meals · 2025-05-15 | Rotateq | $17 |
| Gilead Sciences | Meals · 2025-05-08 | None | $35 |
| ViiV Healthcare | Meals · 2025-05-07 | Apretude | $14 |
| GlaxoSmithKline | Meals · 2025-05-01 | Shingrix | $23 |
| Seqirus USA | Meals · 2025-03-27 | Flucelvax | $24 |
| ViiV Healthcare | Meals · 2025-03-12 | Apretude | $17 |
| Gilead Sciences | Meals · 2025-03-06 | None | $30 |
| Pfizer | Meals · 2025-02-20 | Prevnar 20 | $25 |
| Dynavax Technologies | Meals · 2025-02-13 | Heplisav-B | $20 |
| Sanofi Pasteur | Meals · 2025-02-06 | Vaxelis | $29 |
| Gilead Sciences | Meals · 2025-01-31 | None | $7 |
| ViiV Healthcare | Meals · 2025-01-03 | Apretude | $25 |
See earlier years (2024, 2023)
2024: $357
| Gilead Sciences | None | $98 | 4 payments
|
| ViiV Healthcare | Apretude | $58 | 4 payments
|
| Pfizer | Prevnar 20 | $44 | 2 payments
|
| Hologic Sales and Service | Aptima | $43 | 2 payments
|
| Sanofi Pasteur | Beyfortus | $31 | 1 payment
|
| Amgen | Repatha | $26 | 1 payment
|
| Merck Sharp & Dohme | Gardasil | $24 | 1 payment
|
| Novo Nordisk | Rybelsus | $19 | 1 payment
|
| Phadia US | Immunocap | $16 | 1 payment
|
2023: $113
| GlaxoSmithKline | Shingrix | $35 | 2 payments
|
| Novo Nordisk | Wegovy | $21 | 1 payment
|
| Pfizer | Abrysvo | $19 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $19 | 1 payment
|
| Merck Sharp & Dohme | Pneumovax 23 | $19 | 1 payment
|
Professional record
- NPI
- 1316259864
- Licence
- TX P7349Texas P7349: Canc Non-Renewal
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 5504 Monterey Hwy, San Jose, CA, 95138
- NPI first listed
- 2010-07-12
- NPI last updated
- 2025-12-29
- NPI record certified
- 2025-12-29
This is when the NPI record was last certified, not a medical board exam.